Page 2 - Matthew Vincent Dolan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Matthew vincent dolan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Matthew Vincent Dolan Today - Breaking & Trending Today

DexCom (DXCM) – Investment Analysts' Weekly Ratings Updates

DexCom (NASDAQ: DXCM) recently received a number of ratings updates from brokerages and research firms: 5/1/2024 – DexCom was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating. 4/26/2024 – DexCom had its price target raised by analysts at Raymond James from $151.00 to $160.00. They now have a “strong-buy” rating […] ....

United Kingdom , United States , South Gloucestershire , Matthew Vincent Dolan , Raymond James , Jeremem Sylvain , Canaccord Genuity Group Inc , Fintrust Capital Advisors , News Ratings For Dexcom Inc Daily , Citigroup Inc , Kingswood Wealth Advisors , Dexcom Inc , Commonwealth Equity Services , Cambridge Investment Research Advisors Inc , Securities Exchange Commission , Valeo Financial Advisors , Royal Bank , Canaccord Genuity Group , Com Stock Down , Get Free Report , Vincent Dolan , Exchange Commission , Financial Advisors , Equity Services , Investment Research Advisors , Wealth Advisors ,

Savant Capital LLC Has $13.29 Million Stake in DexCom, Inc. (NASDAQ:DXCM)

Savant Capital LLC decreased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 3.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 107,120 shares of the medical device company’s stock after selling 3,941 shares during the […] ....

United States , United Kingdom , South Gloucestershire , Matthew Vincent Dolan , Kevinr Sayer , Raymond James , Kingswood Wealth Advisors , Cambridge Investment Research Advisors Inc , Valeo Financial Advisors , Royal Bank , Savant Capital , Securities Exchange Commission , Dexcom Inc , Commonwealth Equity Services , Xponance Inc , Free Report , Financial Advisors , Equity Services , Investment Research Advisors , Wealth Advisors , Get Free Report , Vincent Dolan , Exchange Commission , Dexcom Share , Dexcom Real Time , Visit Holdingschannel ,

DexCom (NASDAQ:DXCM) Given New $160.00 Price Target at Raymond James

DexCom (NASDAQ:DXCM) Given New $160.00 Price Target at Raymond James
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Matthew Vincent Dolan , Kevinr Sayer , Raymond James , Commonwealth Equity Services , Dexcom Inc , Slatestone Wealth , Securities Exchange Commission , Royal Bank , Dexcom Company Profile , Principal Financial Group Inc , China Universal Asset Management Co , Canaccord Genuity Group , Free Report , Genuity Group , Moderate Buy , Get Free Report , Exchange Commission , Vincent Dolan , Equity Services , Financial Group , Universal Asset Management , Dexcom Share , Dexcom Real Time , Dexcom Daily ,

DexCom (NASDAQ:DXCM) Posts Earnings Results, Beats Estimates By $0.05 EPS

DexCom (NASDAQ:DXCM) Posts Earnings Results, Beats Estimates By $0.05 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Raymond James , Matthew Vincent Dolan , Kevinr Sayer , Orazio Associates Inc , Stableford Capital , Gulf International Bank United Kingdom Ltd , Securities Exchange Commission , Dexcom Inc , Harbor Investment Advisory , Eversource Wealth Advisors , Royal Bank , Canaccord Genuity Group , Get Free Report , Com Stock Down , Genuity Group , Vincent Dolan , Exchange Commission , International Bank United Kingdom Ltd , Source Wealth Advisors , Investment Advisory , Dexcom Share , Dexcom Real Time , Dexcom Daily ,

DexCom (NASDAQ:DXCM) PT Raised to $145.00

DexCom (NASDAQ:DXCM – Get Free Report) had its price objective raised by equities researchers at Canaccord Genuity Group from $144.00 to $145.00 in a research note issued on Friday, Benzinga reports. The brokerage presently has a “buy” rating on the medical device company’s stock. Canaccord Genuity Group’s price target points to a potential upside of […] ....

United States , Raymond James , Michael Jon Brown , Matthew Vincent Dolan , Norges Bank , Securities Exchange Commission , Capital Research Global Investors , Royal Bank , Artisan Partners Limited Partnership , Canaccord Genuity Group , Dexcom Company Profile , Massachusetts Financial Services Co , Dexcom Inc , Get Free Report , Genuity Group , Jon Brown , Exchange Commission , Vincent Dolan , World Investors , Partners Limited Partnership , Research Global Investors , Massachusetts Financial Services , Dexcom Share , Dexcom Real Time , Dexcom Daily , Nasdaq Dxcm ,